Renal toxicity due to inhaled tobramycin in lung transplant recipients

Journal of Heart and Lung Transplantation

Volumn 25, Issue 5, 2006, Pages 608-

  Laporta, Rosalía ^a   Ussetti, Piedad ^a   Carreño, M Cruz ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; TOBRAMYCIN;

ADULT; BRONCHIOLITIS OBLITERANS; BRONCHITIS; CASE REPORT; CREATININE BLOOD LEVEL; DRUG SAFETY; DRUG WITHDRAWAL; EMPHYSEMA; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; LUNG FIBROSIS; LUNG TRANSPLANTATION; MALE; NEBULIZATION; NEPHROTOXICITY; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ANTI-BACTERIAL AGENTS; CREATININE; HUMANS; KIDNEY; KIDNEY FAILURE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PULMONARY FIBROSIS; TOBRAMYCIN;

EID: 33646140933     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.10.008     Document Type: Letter

References (3)

1. Ahya V.N., Doyle A.M., Mendez J.D., et al. Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient. J Heart Lung Transplant 24 (2005) 932-935
2. Geller D., Pitlick W., Nardella P., Tracewell W., and Ramsey B. Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis. Chest 122 (2002) 219-226
3. Kahler D.A., Schowengerdt K.O., Fricker F.K., Mansfield M., Visner G.A., and Faro A. Toxic serum trough concentrations after administration of nebulized tobramycin. Pharmacotherapy 23 (2003) 543-545